FDA Issues Guidance on Developing Drugs to Treat Epidermolysis Bullosa

By Sam | June 28, 2019

The FDA released final guidance for sponsors of drugs to treat or prevent serious flare-ups of skin disorders known collectively as epidermolysis bullosa (EB).
Source: Drug Industry Daily

Posted in Drug Industry Daily